These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26050354)

  • 21. Validation of Revised FIGO Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type.
    Toptas T; Pestereli E; Erol O; Bozkurt S; Erdogan G; Simsek T
    Int J Gynecol Cancer; 2016 Jul; 26(6):1012-9. PubMed ID: 27206284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
    Barlin JN; Dao F; Bou Zgheib N; Ferguson SE; Sabbatini PJ; Hensley ML; Bell-McGuinn KM; Konner J; Tew WP; Aghajanian C; Chi DS
    Gynecol Oncol; 2012 Jun; 125(3):621-4. PubMed ID: 22446622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and survival analysis of 36 cases of primary fallopian tube carcinoma.
    Ma Y; Duan W
    World J Surg Oncol; 2014 Oct; 12():311. PubMed ID: 25307473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenocarcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 72 patients.
    Wolfson AH; Tralins KS; Greven KM; Kim RY; Corn BW; Kuettel MR; Philippart C; Raub WA; Randall ME
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):71-6. PubMed ID: 9422560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers.
    Benoit MF; Hannigan EV
    Int J Gynecol Cancer; 2006; 16(1):29-35. PubMed ID: 16445606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer.
    Rauh-Hain JA; Foley OW; Winograd D; Andrade C; Clark RM; Vargas RJ; Hinchcliff EM; Esselen KM; Horowitz NS; del Carmen MG
    Am J Obstet Gynecol; 2015 May; 212(5):600.e1-8. PubMed ID: 25514761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer.
    Chang SJ; Bristow RE; Ryu HS
    Gynecol Oncol; 2012 Sep; 126(3):381-6. PubMed ID: 22609747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of advanced ovarian cancer in South West Wales - a comparison between primary debulking surgery and primary chemotherapy treatment strategies in an unselected, consecutive patient cohort.
    Drews F; Bertelli G; Lutchman-Singh K
    Cancer Epidemiol; 2017 Aug; 49():85-91. PubMed ID: 28599137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary fallopian tube carcinoma: a clinicopathological analysis of a rare entity.
    Koo YJ; Im KS; Kwon YS; Lee IH; Kim TJ; Lim KT; Lee KH; Shim JU; Mok JE
    Int J Clin Oncol; 2011 Feb; 16(1):45-9. PubMed ID: 20878435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphadenectomy and optimal excise lymph nodes count for early-stage primary fallopian tube cancer: a SEER-based study.
    Liu Y; Huang F; Gu Q; Wang J; Wang Q; Wu Y; Li L; Xiao Y
    BMC Womens Health; 2023 Dec; 23(1):681. PubMed ID: 38129825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma.
    Coghlan E; Meniawy TM; Munro A; Bulsara M; Stewart CJ; Tan A; Koay MHE; MaGee D; Codde J; Tan J; Salfinger SG; Mohan GR; Leung Y; Nichols CB; Cohen PA
    Int J Gynecol Cancer; 2017 May; 27(4):708-713. PubMed ID: 28441251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary fallopian tube carcinoma - the experience of a UK cancer centre and a review of the literature.
    Clayton NL; Jaaback KS; Hirschowitz L
    J Obstet Gynaecol; 2005 Oct; 25(7):694-702. PubMed ID: 16263546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc-IV high-grade serous ovarian cancer.
    Xu X; Deng F; Lv M; Chen X
    Arch Gynecol Obstet; 2017 Feb; 295(2):451-458. PubMed ID: 27913927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary fallopian tube carcinoma: a retrospective clinicopathologic study.
    Singhal P; Odunsi K; Rodabaugh K; Driscoll D; Lele S
    Eur J Gynaecol Oncol; 2006; 27(1):16-8. PubMed ID: 16550961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 expression in fallopian tube carcinomas.
    Rosen AC; Ausch C; Klein M; Graf AH; Metzenbauer M; Philipp K; Reiner A
    Cancer Lett; 2000 Aug; 156(1):1-7. PubMed ID: 10840153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer.
    Tseng JH; Cowan RA; Afonso AM; Zhou Q; Iasonos A; Ali N; Thompson E; Sonoda Y; O'Cearbhaill RE; Chi DS; Abu-Rustum NR; Long Roche K
    Gynecol Oncol; 2018 Nov; 151(2):287-293. PubMed ID: 30185381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer.
    Xu X; Wang Y; Wang F; Jia L; Zhou Y; Deng F; Qu J; Zhou B; Meng A; Fu B; Chen X; Qian Z; Wang J
    J Ovarian Res; 2013; 6():31. PubMed ID: 23618037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
    J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphadenectomy in Primary Fallopian Tube Cancer is Associated with Improved Survival.
    Xiao Y; Liu YX; Li RN; Wei X; Wang QM; Gu QY; Linghu H
    J Invest Surg; 2022 Jun; 35(6):1417-1423. PubMed ID: 35344678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative serum hCGbeta as a prognostic marker in primary fallopian tube carcinoma.
    Riska A; Alfthan H; Finne P; Jalkanen J; Sorvari T; Stenman UH; Leminen A
    Tumour Biol; 2006; 27(1):43-9. PubMed ID: 16340249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.